2-[(3-Aminoalkyl-(alkaryl-,aryl-))-

Yulya Martynenko, Galina Berest, Nina Bukhtiayrova, Igor Belenichev, Oleksiy Voskoboinik, Sergiy Kovalenko

Abstract read

In one paragraph

Article in Turkish journal of chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yulya MartynenkoDepartment of Organic and Bioorganic Chemistry, Pharmaceutical Faculty, Zaporizhzhia State Medical University, Zaporizhzhia Ukraine.ORCID https://orcid.org/0000-0002-7751-4769

Galina BerestDepartment of Organic and Bioorganic Chemistry, Pharmaceutical Faculty, Zaporizhzhia State Medical University, Zaporizhzhia Ukraine.ORCID https://orcid.org/0000-0001-6718-1713

Nina BukhtiayrovaDepartment of Pharmacology and Medical Formulation, Pharmaceutical Faculty, Zaporizhzhia State Medical University, Zaporizhzhia Ukraine.ORCID https://orcid.org/0000-0003-3499-3111

Igor BelenichevDepartment of Pharmacology and Medical Formulation, Pharmaceutical Faculty, Zaporizhzhia State Medical University, Zaporizhzhia Ukraine.ORCID https://orcid.org/0000-0003-1273-5314

Oleksiy VoskoboinikDepartment of Organic and Bioorganic Chemistry, Pharmaceutical Faculty, Zaporizhzhia State Medical University, Zaporizhzhia Ukraine.ORCID https://orcid.org/0000-0002-5790-3564

Sergiy KovalenkoDepartment of Organic and Bioorganic Chemistry, Pharmaceutical Faculty, Zaporizhzhia State Medical University, Zaporizhzhia Ukraine.ORCID https://orcid.org/0000-0001-8017-9108

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The presented work is devoted to the development of synthesis methods for novel 2-[(3-aminoalkyl-(alkaryl-, aryl-))-1H-1,2,4-triazolo]anilines. Abovementioned compounds were obtained via hydrazinolysis (Ing-Manske procedure) and acid hydrolysis of corresponding N -acylated{([1,2,4]triazolo[1,5-c]quinazolin-2-yl)alkyl-(alkaryl-, aryl-)}amines. The regioselectivity of hydrazinolysis and hydrolysis were established. The features of spectral characteristics werestudied and discussed. Characteristic patterns of protons signals splitting in

Indexed as

2-[(3-aminoalkyl-(alkaryl-,aryl-))-1H-1,2,4-triazolo]anilinesacidic hydrolysisanticonvulsant activityhydrazinolysisN -acylated{([1,2,4]triazolo[1,5-c]quinazolin-2-yl)alkyl-(alkaryl-, aryl-)}amines

Identifiers

PMID33488191

DOI10.3906/kim-2002-24

PMCPMC7671191

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.